Previous 10 | Next 10 |
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, and its digital health subsidiary Veris Health (“Veris”) today announced the appointment of Silicon Valley technology executive ...
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the appointment of highly accomplished molecular biologist Suman...
Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the appointment of highly accomplished molecular biologist Suman...
NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”) a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), today announced the closing on October 1...
Listen on the go! A daily podcast of Wall Street Breakfast's Alpha Talks will be available this morning on Seeking Alpha, iTunes, Stitcher and Spotify. The S&P 500 wrapped up its best week since July, closing at its highest level in a month, as a series of upside earnings reports from Wal...
While the S&P 500 index added ~1.8% gain over the week, its healthcare constituents underperformed with a ~0.8% rise yet, recording their first weekly gain in more than a month. Dragged down by pharma stocks, the sector became the second-worst performer in the index for ano...
Favorable economic news and strong earnings figures helped spark a substantial rally on Thursday, with the S&P 500 scoring its best single-day performance in seven months. Dow component Salesforce.com Inc. (NYSE:CRM) used the tailwind to extend its recent gains, pushing to new 52-week hig...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Among the various stocks investors have on their radar today is PAVmed (NASDAQ: PAVM ). Today, shares of PAVM stock are seeing precipitous declines, down more than 13% at the time of writing. Source: sfam_photo / S...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Yet another Lucid IPO (initial public offering) is underway. That’s right. Today marks the start of trading for Lucid Diagnostics (NASDAQ: LUCD ) and LUCD stock. Investors awaiting the highly anticipated L...
Gainers: Grove (NASDAQ:GRVI) +62%. NRx Pharmaceuticals (NASDAQ:NRXP) +35%. Connect Biopharma (NASDAQ:CNTB) +23%. Huttig Building Products (NASDAQ:HBP) +20%. KORE (NYSE:KORE) +20%. DarioHealth (NASDAQ:DRIO) +19%. Broadwind (NASDAQ:BWEN) +19%. Cemtrex (NASDAQ:CETX) +17%. Annovis (NYSE:ANVS) +17...
News, Short Squeeze, Breakout and More Instantly...
Lucid Diagnostics Announces Record Quarterly EsoGuard® Test Volume PR Newswire Quarterly EsoGuard ® test volume increased 31 percent sequentially NEW YORK , July 23, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("L...
Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK , July 11, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and majority-ow...
Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population PR Newswire Prospective screening study demonstrates excellent EsoGuard s...